Back to search

Aristotle University Of Thessaloniki (AUTH)

Διερεύνηση του πολυμορφισμού των γονιδίων κυκλοοξυγενάσης 2 και λιποπρωτεϊνικής φωσφωλιπάσης Α2 σε ασθενείς με οξύ στεφανιαίο σύνδρομο

Abstract

dc:description

Atherosclerosis is the most common cause of ischemic coronary artery disease. Prostaglandins seem to have a crucial role in the pathophysiology of atherosclerosis. Cyclooxygenase (COX) is the key enzyme for prostaglandin production. COX2 is an isoenzyme of COX, its synthesis is promoted by proinflammatory factors and it seems that is involved in the process of atherogenesis through increase of the permeability of blood vessel wall, smooth muscle cell proliferation and increased plaque instability.Lipoprotein phospholipase A2 (Lp-PLA2) is an enzyme hydrolyzing platelet activating factor (PAF) and oxidized phospholipids in the subendothelial space, promoting the release of proinflammatory and proatherogenic factors. Several polymorphisms of the Lp-PLA2 gene have been described. Some of them have been associated with increased cardiovascular disease (CVD) risk, as they seem to be involved with the instability of the atherosclerotic plaque, whereas others have been associated with the presence of small, dense LDL molecules. Aim: The aim of the present study was the investigation of possible relation between Lp-PLA2 and COX2 genes and known atherosclerosis risk factors, inflammatory and lipidaemic, to find new risk markers for coronary artery disease. The early identification of polymorphisms of these genes may help in the prevention of acute coronary events in the members of the families of the patients. To our knowledge, such an investigation of these polymorphisms in relation to lipid profile, inflammation and oxidation markers has not been made before. Materials and methods: In the study group, 69 patients with acute coronary syndrome under no medication were included in the study. They were compared to 34 healthy adults of comparable age, with no personal or family history of cardiovascular or other disease. Blood was drawn after 12-hour fast and samples were kept in -80°C. Parameters studied included lipid panel [total cholesterol, HDL, LDL, triglycerides, apoA-I, apoB-100, Lp(a)], uric acid (UA), high sensitive C-reactive protein (hsCRP), oxidized LDL (oxLDL) and prostaglandin E2 (PGE2). DNA was extracted and -765G>C COX-2 gene polymorphism, as well as A379V and V279F polymorphisms of Lp-PLA2 gene were studied. Results: Comparison of parameters between the two groups showed significantly higher hsCRP levels in the study group and lower HDL and ApoA-I levels. In total, between the subgroups of -765G>C COX 2 gene polymorphism there were no statistically significant differences in any parameters. The same observation was made by the comparisons between the subgroups of A379V Lp-PLA2 gene polymorphism, in the total number of participants in the study, patients and controls. Studying the two groups separately, comparison of parameters between the subgroups of different genotype of -765G>C no statistically significant difference was observed. Comparison of parameters between subjects of the same genotype between the two groups revealed higher levels of hsCRP in the GC genotype and lower levels of HDL and ApoA-I in the study than in the control group. No significant difference in the levels of PGE2 was found between subject of different genotype of -765G>C COS2 gene polymorphism. In reference to A379V polymorphism of Lp-PLA2 gene, comparison of parameters among subjects of different genotype, GG, GA, AA, showed increased levels of triglycerides in GA group. Subjects of GG group had statistically significant higher hsCRP and Lp(a) levels and lower HDL and ApoA-I serum levels than controls, whereas subjects of GA group presented with even higher hsCRP levels and lower HDL and ApoA-I serum levels than GA controls. No subject had AA genotype in the group of controls. In the group of CC genotype of V279F polymorphism of gene Lp-PLA2 the above-mentioned significant differences were also observed. After performing Spearman’s correlation between hsCRP, oxLDL, PGE2 and lipid parameters in the total number of subjects there was significant positive correlation of hsCRP with oxLDL, whereas no such correlation was observed in the control group. Conclusions: The variation of oxLDL and PGE2 values, in contrast to known risk factors for coronary artery disease did not differ between the two groups. The recessive allele of V279F polymorphism was not found. Inflammation and oxidation co-exist in patients with coronary artery. Oxidation and inflammation seem to co-exist in patients with acute coronary syndrome. There was neither significant correlation between oxLDL or PGE2 with lipid parameters or uric acid, nor significant difference between patients and controls. Nevertheless, it was obvious that there is a connection between the polymorphisms of the two genes studied, lipid profile and PGE2, and with oxidation and inflammation, as expressed by ox-LDL and hsCRP, respectively. In conclusion, the present study showed that it seems to be a relation between COX2 and Lp-PLA2 gene polymorphisms that have been studied to coronary artery disease but these results have to be further investigated with a larger sample to be confirmed.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papadopoulou, Dimitroula
  • Παπαδοπούλου, Δημητρούλα

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48891

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papadopoulou, Dimitroula; Παπαδοπούλου, Δημητρούλα. Διερεύνηση του πολυμορφισμού των γονιδίων κυκλοοξυγενάσης 2 και λιποπρωτεϊνικής φωσφωλιπάσης Α2 σε ασθενείς με οξύ στεφανιαίο σύνδρομο. Aristotle University Of Thessaloniki (AUTH), 2021. http://hdl.handle.net/10442/hedi/48891